These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7232846)

  • 1. PCNU Phase I study in the North California Oncology Group.
    Friedman MA
    Recent Results Cancer Res; 1981; 76():125-9. PubMed ID: 7232846
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of PCNU in colorectal carcinoma.
    Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
    Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trail of PCNU in refractory advanced breast cancer.
    Kavanagh JJ; Yap HY; Blumenschein GR; Stewart D; Bodey GP
    Am J Clin Oncol; 1982 Jun; 5(3):249-51. PubMed ID: 7081144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA; Liu J; Weinkam RJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNU: a new nitrosourea in clinical oncology.
    Poster DS; Penta JS; Bruno S
    Am J Clin Oncol; 1982 Feb; 5(1):9-12. PubMed ID: 7081143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of PCNU in breast carcinoma.
    Rubins JM; Taylor SG
    Invest New Drugs; 1989 Jul; 7(2-3):239-41. PubMed ID: 2793380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNU in advanced adenocarcinoma of the ovary: a phase II study.
    Decker DA; Samson MJ; Baker LH
    Cancer Treat Rep; 1983 May; 67(5):511-2. PubMed ID: 6850668
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma.
    Klenner T; Berger MR; Eisenbrand G; Schmähl D
    Br J Cancer; 1989 Mar; 59(3):335-40. PubMed ID: 2930696
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
    Chapman RA; Natale RB; Young CW; Wittes RE
    Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanoma.
    Harvey JH; Smith FP; Bowers MW; Neefe JR; Butler TP; Gullo JJ; Schertz G; Lokey J; Schein PS; Woolley PV
    Cancer Treat Rep; 1984; 68(7-8):1049-50. PubMed ID: 6744340
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of potential anticancer agents. 38. N-Nitrosoureas. 4. Further synthesis and evaluation of haloethyl derivatives.
    Johnston TP; McCaleb GS; Opliger PS; Laster WR; Montgomery JA
    J Med Chem; 1971 Jul; 14(17):600-14. PubMed ID: 5170822
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of GANU and MCNU.
    Ogawa M
    Cancer Treat Rev; 1980 Dec; 7(4):197-203. PubMed ID: 6452200
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
    Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
    J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCNU in advanced breast cancer.
    Martino S; Samal BA; Singhakowinta A
    Cancer Treat Rep; 1983 Mar; 67(3):305-6. PubMed ID: 6831478
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of nitrosoureas under development in Japan.
    Ogawa M; Fujimoto S
    Recent Results Cancer Res; 1981; 76():115-24. PubMed ID: 6453413
    [No Abstract]   [Full Text] [Related]  

  • 19. PCNU and recurrent childhood brain tumors.
    Allen JC; Hancock C; Walker R; Tan C
    J Neurooncol; 1987; 5(3):241-4. PubMed ID: 3681386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCNU treatment for recurrent malignant gliomas.
    Levin VA; Resser KJ; McGrath L; Vestnys P; Nutik S; Wilson CB
    Cancer Treat Rep; 1984; 68(7-8):969-73. PubMed ID: 6744348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.